PhD, All India Institute of Medical Sciences, India
MSc, Banaras Hindu University, India
BSc, Agra University, India
Dr. Kumar's current interests are on the development of a vaccine to stop transmission of human malaria caused by Plasmodium falciparum and Plasmodium vivax. Understanding mechanisms of sexual differentiation of Plasmodium and interaction with the anopheline mosquito vector guide the rational design of vaccines targeting the transmission process. Current focus of these vaccine studies includes: (1) recombinant expression of vaccine antigens, (2) optimization of immune responses of vaccine antigens formulated with various adjuvants including nanosomes and nanoparticles, (3) development of DNA vaccine combinations to interrupt malaria transmission, and (4) understanding immune correlates of vaccine efficacy and safety. In other studies, he is also investigating DNA damage response mechanisms in Plasmodium, especially during exposure to anti-malarial drugs such as artemisinin. Another growing interest (animal models and field studies) of the Kumar lab is to investigate parasitologic and immune interactions during malaria and helminth coinfections. Dr. Kumar currently teaches inhree graduate level immune courses (immunology, immunoparasitology, and malariology). As a director of Vector-Borne Infectious Disease Research Center (VBIDRC), he is providing leadership for the establishment of transdisciplinary collaborative research programs combining expertise of more than a dozen faculty members from various schools and departments at Tulane and focusing on a number of vector-borne infectious diseases.
Please view Dr. Kumar's publications at his NCBI profile page.